The use of chemotherapy in patients with gliomas: Patterns of care in Victoria from 1998–2000
Authors:
- Mark A. RosenthalMRMark A. Rosenthal
- Katharine J. DrummondKDKatharine J. Drummond
- Michael DallyMDMichael Dally
- Michael MurphyMMMichael Murphy
- David AshleyDADavid Ashley
- Vicky ThursfieldVTVicky Thursfield
- Graham G. GilesGGGraham G. Giles
- 30 April 2008
- journal article
- research article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 15 (4) , 398-401
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with OligodendrogliomaCancer Research, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- BCNU as second line therapy for recurrent high-grade glioma previously treated with TemozolomideJournal of Clinical Neuroscience, 2004
- Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomasCancer, 2003
- Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trialsThe Lancet, 2002
- An Australian experience with temozolomide for the treatment of recurrent high grade gliomasJournal of Clinical Neuroscience, 2001
- Brain TumorsNew England Journal of Medicine, 2001
- A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseBritish Journal of Cancer, 2000
- Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First RelapseJournal of Clinical Oncology, 1999
- Procarbazine, lomustine, and vincristine (PCV) chemotherapy for Grade III and Grade IV oligoastrocytomasJournal of Neurosurgery, 1996